BOSTON, April 18, 2024--PureTech Health: Notice of Results
BOSTON, April 16, 2024--PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
BOSTON, April 11, 2024--PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers